These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 15769809
21. Treatment of hypertension in chronic kidney disease. Toto RD. Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [Abstract] [Full Text] [Related]
22. CKD progression and mortality among older patients with diabetes. Patel UD, Young EW, Ojo AO, Hayward RA. Am J Kidney Dis; 2005 Sep; 46(3):406-14. PubMed ID: 16129201 [Abstract] [Full Text] [Related]
23. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM. Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016 [Abstract] [Full Text] [Related]
24. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Jones C, Roderick P, Harris S, Rogerson M. Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779 [Abstract] [Full Text] [Related]
25. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574 [Abstract] [Full Text] [Related]
26. Beta-blockers for coronary heart disease in chronic kidney disease. Chonchol M, Benderly M, Goldbourt U. Nephrol Dial Transplant; 2008 Jul; 23(7):2274-9. PubMed ID: 18187497 [Abstract] [Full Text] [Related]
27. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saito A, Bragg-Gresham JL, Gillespie BW, Young EW. Hemodial Int; 2006 Apr; 10(2):180-8. PubMed ID: 16623672 [Abstract] [Full Text] [Related]
28. Predictors of new-onset decline in kidney function in a general middle-european population. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R. Nephrol Dial Transplant; 2008 Apr; 23(4):1265-73. PubMed ID: 18039642 [Abstract] [Full Text] [Related]
29. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876 [Abstract] [Full Text] [Related]
30. [Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. Rottlaender D, Scherner M, Schneider T, Erdmann E. Dtsch Med Wochenschr; 2007 Jan 26; 132(4):139-44. PubMed ID: 17230328 [Abstract] [Full Text] [Related]
31. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study. Banasiak W, Wilkins A, Pociupany R, Ponikowski P. Kardiol Pol; 2008 Jun 26; 66(6):642-9; discussion 650. PubMed ID: 18626833 [Abstract] [Full Text] [Related]
32. Use of secondary preventive medications after the first attack of acute coronary syndrome. Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T. Eur J Cardiovasc Prev Rehabil; 2007 Jun 26; 14(3):386-91. PubMed ID: 17568237 [Abstract] [Full Text] [Related]
33. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL. Am J Kidney Dis; 2009 Apr 26; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [Abstract] [Full Text] [Related]
34. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives. Williams AF, Manias E, Walker R. Int J Nurs Stud; 2008 Dec 26; 45(12):1742-56. PubMed ID: 18701103 [Abstract] [Full Text] [Related]
35. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease. Spinowitz BS, Pratt RD, Epoetin Delta 2002 Study Group. Curr Med Res Opin; 2006 Dec 26; 22(12):2507-13. PubMed ID: 17166333 [Abstract] [Full Text] [Related]
36. Gender differences in pharmacological and clinical associates of kidney disease. A hospital-based study. Sweileh WM. Med Princ Pract; 2008 Dec 26; 17(2):102-7. PubMed ID: 18287792 [Abstract] [Full Text] [Related]
37. Effect of pravastatin in people with diabetes and chronic kidney disease. Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G. J Am Soc Nephrol; 2005 Dec 26; 16(12):3748-54. PubMed ID: 16251235 [Abstract] [Full Text] [Related]
38. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA. Interact Cardiovasc Thorac Surg; 2008 Apr 26; 7(2):231-4. PubMed ID: 18234766 [Abstract] [Full Text] [Related]
39. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS. Nephrol Dial Transplant; 2004 Jul 26; 19(7):1842-8. PubMed ID: 15128886 [Abstract] [Full Text] [Related]
40. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group. Curr Med Res Opin; 2008 Mar 26; 24(3):625-37. PubMed ID: 18208642 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]